Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP557668.RApylE602IaGIRmKPhFifKLzLBk37mLfpDsf3kGiIjjVI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP557668.RApylE602IaGIRmKPhFifKLzLBk37mLfpDsf3kGiIjjVI130_assertion type Assertion NP557668.RApylE602IaGIRmKPhFifKLzLBk37mLfpDsf3kGiIjjVI130_head.
- NP557668.RApylE602IaGIRmKPhFifKLzLBk37mLfpDsf3kGiIjjVI130_assertion description "[Firstly, 22 transcripts are identified to have new roles in modulating the DAS28 score; secondly, there are 6 transcripts that could be alternative targets to TNF-? blocker therapies, including CD86--a component of the signaling axis targeted by Abatacept (CTLA4-Ig), and finally, 59 transcripts that are predicted to modulate the count of tender or swollen joints but not sufficiently enough to have a significant impact on DAS28.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557668.RApylE602IaGIRmKPhFifKLzLBk37mLfpDsf3kGiIjjVI130_provenance.
- NP557668.RApylE602IaGIRmKPhFifKLzLBk37mLfpDsf3kGiIjjVI130_assertion evidence source_evidence_literature NP557668.RApylE602IaGIRmKPhFifKLzLBk37mLfpDsf3kGiIjjVI130_provenance.
- NP557668.RApylE602IaGIRmKPhFifKLzLBk37mLfpDsf3kGiIjjVI130_assertion SIO_000772 21423713 NP557668.RApylE602IaGIRmKPhFifKLzLBk37mLfpDsf3kGiIjjVI130_provenance.
- NP557668.RApylE602IaGIRmKPhFifKLzLBk37mLfpDsf3kGiIjjVI130_assertion wasDerivedFrom befree-20140225 NP557668.RApylE602IaGIRmKPhFifKLzLBk37mLfpDsf3kGiIjjVI130_provenance.
- NP557668.RApylE602IaGIRmKPhFifKLzLBk37mLfpDsf3kGiIjjVI130_assertion wasGeneratedBy ECO_0000203 NP557668.RApylE602IaGIRmKPhFifKLzLBk37mLfpDsf3kGiIjjVI130_provenance.